Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $389,512 | $455,947 | $374,911 | $506,755 |
| - Cash | $59,839 | $53,710 | $110,068 | $109,227 |
| + Debt | $41,271 | $39,865 | $70,462 | $36,575 |
| Enterprise Value | $370,944 | $442,102 | $335,305 | $434,103 |
| Revenue | $195,041 | $213,054 | $200,473 | $187,926 |
| % Growth | -8.5% | 6.3% | 6.7% | – |
| Gross Profit | $116,415 | $130,859 | $112,992 | $74,320 |
| % Margin | 59.7% | 61.4% | 56.4% | 39.5% |
| EBITDA | $17,573 | $24,505 | $23,367 | -$110,494 |
| % Margin | 9% | 11.5% | 11.7% | -58.8% |
| Net Income | -$68,291 | -$25,545 | -$103,681 | -$70,552 |
| % Margin | -35% | -12% | -51.7% | -37.5% |
| EPS Diluted | -0.89 | -0.25 | -1.24 | -0.87 |
| % Growth | -256% | 79.8% | -42.5% | – |
| Operating Cash Flow | $30,499 | -$13,030 | $13,421 | -$25,194 |
| Capital Expenditures | -$5,404 | -$6,872 | -$4,776 | -$16,194 |
| Free Cash Flow | $25,095 | -$19,902 | $8,645 | -$41,388 |